Difference between revisions of "User:William J. Gibson"

From OpenWetWare
Jump to: navigation, search
Line 1: Line 1:
{{New user}}
[[Modulation of SIR3 Activity and Effects on Aging in Annelids]]
==Contact Info==
[[Image:Will_Gibson.jpg|thumb|right|William J. Gibson (an artistic interpretation)]]
*William J. Gibson
*William J. Gibson
Line 12: Line 6:
*[[Special:Emailuser/William J. Gibson|Email me through OpenWetWare]]
*[[Special:Emailuser/William J. Gibson|Email me through OpenWetWare]]
*I work in the Edelman Lab at MIT.  I learned about [[OpenWetWare]] from My instructors at MIT, and I've joined because of 20.109.
*I'm from Natick MA, and enjoy sports, research, reading, learning generally, hanging with my friends, trying to make myself and the world better. My favorite kind of ice cream is the now retired Ben and Jerry's ® One Sweet Whirled.
<!--Include info about your educational background-->
S.B Candidate Biological Engineering - MIT
S.B Candidate Philosophy - MIT (might only minor)
S.B Biological Engineering - MIT
S.B Philosophy - MIT
[http://web.mit.edu/wgibson/Public/Curriculum%20Vitae.pdf C.V.]
==Research interests==
==Research interests==
Line 44: Line 35:
at 1 year.nd
at 1 year.nd
==Registration/Questionnaire: 20.109 Spring 2008==
===Last Name===
===First Name===
===Preferred name===
===Year of Graduation===
===Telephone #===
wgibson AT mit DOT edu
===Have you taken===
7.05/5.07 (Biochemistry)<br>
7.06 (Cell Biology)<br>
7.02 (General Biology Lab)<br>
5.310 (General Chemistry Lab)<br>
Have you taken any of these classes?
Currently taking 7.05
Do you have any experience culturing cells (mammalian, yeast or microbial)? No.<br>
Do you have any experience in molecular biology (electrophoresis, PCR, etc)? No.<br>
===Please briefly describe any previous laboratory experience===
In high school I worked in a lab that did quantitative coronary angiography for clinical trials.  Now, I work at the Edelman Lab on in-vitro models of thrombosis so while I feel comfortable in lab, I am not familiar with the techniques we will learn.
===Anything else you would like us to know?===
I'm currently reading Mountains Beyond Mountains, The Cathedral Within, and Portnoy's Complaint.  I might have trouble focusing.  
==Useful links==
==Useful links==
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[Help|OpenWetWare help pages]]
*[[Help|OpenWetWare help pages]]

Revision as of 22:16, 25 October 2010


S.B Biological Engineering - MIT

S.B Philosophy - MIT

Research interests

  1. Cardiology (in-vitro models of thrombosis, PCI, coagulation, endothelialization, treating atherosclerosis)
  2. Drug Delivery: Finding ways to deliver drug locally.
  3. Aging: I watched this documentary on PBS about SIR-2 which was pretty cool.


  1. Olenchock SA Jr, Karmpaliotis D, Gibson WJ, Murphy SA, Southard MC, Ciaglo L, Buros J, Mack MJ, Alexander JH, Harrington RA, Califf RM, Kouchoukos NT, Ferguson TB Jr, and Gibson CM. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. Ann Thorac Surg. 2008 Feb;85(2):520-4. DOI:10.1016/j.athoracsur.2007.10.061 | PubMed ID:18222256 | HubMed [Paper1]
  2. Gibson WJ and Gibson CM. The association of impaired myocardial perfusion and monocytosis with late recovery of left ventricular function following primary percutaneous coronary intervention. Eur Heart J. 2006 Nov;27(21):2487-8. DOI:10.1093/eurheartj/ehl267 | PubMed ID:17000630 | HubMed [Paper2]
  3. Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane AJ, Karha J, Aroesty JM, Giugliano RP, Antman EM, and TIMI Study Group.. Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction. Am J Cardiol. 2003 Sep 1;92(5):595-7. PubMed ID:12943884 | HubMed [Paper3]
All Medline abstracts: PubMed | HubMed


Ciaglo LN, Karmpaliotis D, Olenchock ,Jr. SA, Gibson WJ, Buros JL, Perez L, Lew M, Harrington RA, Mack MJ, Ferguson, Jr. TB, Kouchoukos NT, Alexander JH, Gibson CM. Rate of TIMI flow grade 3 in saphenous vein grafts (SVG) and native coronary arteries across varying vein graft diameters at 1 year.nd

Useful links